← SynDRA
phenylacetylglutamine
SynDRA canonical compound SYN0079282 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | DNA methylase inhibitor | protein synthesis inhibitor |
Mechanisms of action (all sources)
- DNA methylase inhibitor
- protein synthesis inhibitor
Cross-references
Synonyms
- Phenylacetyl L-Glutamine
- L-Glutamine, N2-(phenylacetyl)-
- (2S)-5-amino-5-oxo-2-[(2-phenylacetyl)amino]pentanoic acid
- NSC 203800
- ASTUGENAL COMPONENT PHENYLACETYLGLUTAMINE
- ANTINEOPLASTON AS2-1 COMPONENT PHENYLACETYLGLUTAMINE
- ANTINEOPLASTON AS 2-1 COMPONENT PHENYLACETYLGLUTAMINE
- (2S)-5-amino-5-oxo-2-((2-phenylacetyl)amino)pentanoic acid
- RefChem:861691
- DTXCID00104815
- PHENYLAC-GLN-OH
- (S)-5-Amino-5-oxo-2-(2-phenylacetamido)pentanoic acid
- alpha-N-Phenylacetyl-L-glutamine
- MFCD01725188
- L-N(sup 2)-(Phenylacetyl)glutamine
- Glutamine, N2-(phenylacetyl)-, L-
- N(2)-phenylacetyl-L-glutamine
- N2-(2-Phenylacetyl)-L-glutamine
- N(2)-(phenylacetyl)-L-glutamine
- PA-L-Glutamine
- (2S)-4-carbamoyl-2-(2-phenylacetamido)butanoic acid
- N-Phenylacetyl-L-glutamine (Phenylacetylglutamine)
- BRN 2593680
- N-PhenylAc-Gln-OH
- Glutamine, N(sup 2)-(phenylacetyl)-, L-
- 3-09-00-02227 (Beilstein Handbook Reference)
- PhenylAc-Gln-OH, AldrichCPR
- SCHEMBL236527
- orb1301942
- orb3033013
- orb3141131
- (S)-5-Amino-5-oxo-2-(2-phenylacetamido)pentanoicacid
- UNII-92358I79RG
- CHEBI:17884
- PHENYLACETYLGLUTAMINE [MI]
- N~2~-(Phenylacetyl)-L-glutamine
- MSK15417
- PHENYLACETYLGLUTAMINE [WHO-DD]
Look up phenylacetylglutamine in the interactive SynDRA portal →